EE200300007A - Heterotsüklilised tetrahüdropüridino- või piperidinoderivaadid - Google Patents

Heterotsüklilised tetrahüdropüridino- või piperidinoderivaadid

Info

Publication number: EE200300007A
Authority: EE; Estonia
Prior art keywords: tetrahydropyridine; piperidine; heterocyclic derivatives; heterocyclic; derivatives
Prior art date: 2000-07-05

Application number

EEP200300007A

Other languages

English (en)

Inventor

Nakazato Atsuro

Kumagai Toshihito

Okubo Taketoshi

Kameo Kazuya

Original Assignee

Taisho Pharmaceutical Co., Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-05

Filing date

2001-07-04

Publication date

2004-08-16

2001-07-04 Application filed by Taisho Pharmaceutical Co., Ltd. filed Critical Taisho Pharmaceutical Co., Ltd.

2004-08-16 Publication of EE200300007A publication Critical patent/EE200300007A/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Hematology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Addiction (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

EEP200300007A 2000-07-05 2001-07-04 Heterotsüklilised tetrahüdropüridino- või piperidinoderivaadid EE200300007A (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000204021		2000-07-05
JP2000270535		2000-09-06
PCT/JP2001/005806 WO2002002549A1 (en)	2000-07-05	2001-07-04	Tetrahydropyridino or piperidino heterocyclic derivatives

Publications (1)

Publication Number	Publication Date
EE200300007A true EE200300007A (et)	2004-08-16

Family

ID=26595443

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300007A EE200300007A (et)	2000-07-05	2001-07-04	Heterotsüklilised tetrahüdropüridino- või piperidinoderivaadid

Country Status (24)

Country	Link
US (2)	US6852732B2 (et)
EP (1)	EP1299378B1 (et)
JP (1)	JP2004502685A (et)
KR (1)	KR20030015368A (et)
CN (2)	CN1535968A (et)
AR (1)	AR028782A1 (et)
AT (1)	ATE353885T1 (et)
AU (2)	AU2001269437B2 (et)
BG (1)	BG107374A (et)
BR (1)	BR0112166A (et)
CA (1)	CA2412287A1 (et)
CZ (1)	CZ20024229A3 (et)
DE (1)	DE60126616T2 (et)
EA (1)	EA005289B1 (et)
EE (1)	EE200300007A (et)
HR (1)	HRP20030074A2 (et)
HU (1)	HUP0301165A2 (et)
IL (1)	IL153718A0 (et)
MX (1)	MXPA02012820A (et)
NO (1)	NO20026125L (et)
PL (1)	PL358411A1 (et)
SK (1)	SK132003A3 (et)
TW (1)	TW591022B (et)
WO (1)	WO2002002549A1 (et)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6900226B2 (en) *	2000-09-06	2005-05-31	Hoffman-La Roche Inc.	Neuropeptide Y antagonists
GB0117396D0 (en)	2001-07-17	2001-09-05	Glaxo Group Ltd	Chemical compounds
AR042667A1 (es) *	2002-12-26	2005-06-29	Taisho Pharmaceutical Co Ltd	Derivados de pirrolopirimidina y pirrolopiridina sustituidos con un grupo amino ciclico
EP1927594A1 (en) *	2003-01-14	2008-06-04	Arena Pharmaceuticals, Inc.	1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
HRP20050696B1 (en) *	2003-01-14	2008-10-31	Arena Pharmaceuticals Inc.	1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
GB0308208D0 (en)	2003-04-09	2003-05-14	Glaxo Group Ltd	Chemical compounds
US7268133B2 (en) *	2003-04-23	2007-09-11	Pfizer, Inc. Patent Department	Cannabinoid receptor ligands and uses thereof
TWI287010B (en)	2003-06-12	2007-09-21	Euro Celtique Sa	Therapeutic agents useful for treating pain
AR045047A1 (es)	2003-07-11	2005-10-12	Arena Pharm Inc	Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
US7132426B2 (en)	2003-07-14	2006-11-07	Arena Pharmaceuticals, Inc.	Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ATE519486T1 (de) *	2003-10-16	2011-08-15	Neurosearch As	Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer
US20070293511A1 (en) *	2003-12-22	2007-12-20	Sb Pharmco Puerto Rico Inc. And Neurocrine Biosciences, Inc., A Corporation	Crf Receptor Antagonists and Methods
CA2552503C (en) *	2004-01-06	2011-09-13	Taisho Pharmaceutical Co., Ltd.	Pyrrolopyrimidine and pyrrolotriazine derivatives
ATE356129T1 (de)	2004-01-06	2007-03-15	Taisho Pharmaceutical Co Ltd	Triazacyclopenta(cd)indenderivate
JP2007517793A (ja) *	2004-01-06	2007-07-05	大正製薬株式会社	環状アミノ基によって置換されたチエノピリミジン及びチエノピリジン誘導体
US20070270588A1 (en) *	2004-03-05	2007-11-22	Taisho Pharmaceutical Co., Ltd.	Pyrrolopyrimidine Derivatives
JP2007161585A (ja) *	2004-06-25	2007-06-28	Taisho Pharmaceut Co Ltd	環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
BRPI0512514A (pt) *	2004-06-25	2008-03-11	Taisho Pharmaceutical Co Ltd	composto, antagonista para receptores de crf, e, uso de um composto
US20060128729A1 (en) *	2004-11-23	2006-06-15	Manojit Pal	Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them
MX2008010953A (es) *	2006-02-28	2008-09-08	Amgen Inc	Derivados de cinolina y quinoxalina como inhibidores de la fosfodiesterasa 10.
ES2301380B1 (es)	2006-08-09	2009-06-08	Laboratorios Almirall S.A.	Nuevos derivados de 1,7-naftiridina.
EA200900960A1 (ru) *	2007-01-31	2010-02-26	Новартис Аг	Производные пиперидинацетамида для лечения воспалительных или аллергических заболеваний
ES2320955B1 (es)	2007-03-02	2010-03-16	Laboratorios Almirall S.A.	Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es)	2007-04-26	2010-09-23	Laboratorios Almirall S.A.	Nuevos derivados de 4,8-difenilpoliazanaftaleno.
ES2571533T3 (es)	2007-04-27	2016-05-25	Purdue Pharma Lp	Antagonistas de TRPV1 y usos de los mismos
JP5372913B2 (ja)	2007-04-27	2013-12-18	パーデュー、ファーマ、リミテッド、パートナーシップ	疼痛治療に有効な治療薬
EP2108641A1 (en)	2008-04-11	2009-10-14	Laboratorios Almirall, S.A.	New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en)	2008-04-28	2009-11-04	Laboratorios Almirall, S.A.	New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
MX2013003184A (es)	2010-09-22	2013-06-07	Arena Pharm Inc	Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo.
MX2013007937A (es)	2011-01-07	2013-11-01	Taiho Pharmaceutical Co Ltd	Nuevo derivado de indol o indazol o sal del mismo.
TW201309668A (zh)	2011-01-07	2013-03-01	Taiho Pharmaceutical Co Ltd	新穎雙環式化合物或其鹽
ES2620528T3 (es)	2011-06-22	2017-06-28	Purdue Pharma Lp	Antagonistas de TRPV1 que incluyen un sustituyente dihidroxi y usos de los mismos
US11007175B2 (en)	2015-01-06	2021-05-18	Arena Pharmaceuticals, Inc.	Methods of treating conditions related to the S1P1 receptor
BR112017027656B1 (pt)	2015-06-22	2023-12-05	Arena Pharmaceuticals, Inc.	Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
AU2016378723B2 (en)	2015-12-22	2021-09-30	SHY Therapeutics LLC	Compounds for the treatment of cancer and inflammatory disease
US10577362B2 (en) *	2016-05-04	2020-03-03	Genoscience Pharma	Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases
CA3053418A1 (en)	2017-02-16	2018-08-23	Arena Pharmaceuticals, Inc.	Compounds and methods for treatment of primary biliary cholangitis
MA49458A (fr)	2017-06-21	2020-04-29	SHY Therapeutics LLC	Composés interagissant avec la superfamille ras destinés à être utilisés dans le traitement de cancers, de maladies inflammatoires, de rasopathies et de maladies fibrotiques
BR112020024762A2 (pt)	2018-06-06	2021-03-23	Arena Pharmaceuticals, Inc.	métodos de tratamento de condições relacionadas ao receptor s1p1
EP3898609A1 (en)	2018-12-19	2021-10-27	Shy Therapeutics LLC	Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
EP3838847B1 (en)	2019-12-20	2024-04-17	Industrial Technology Research Institute	Composite material and method of removing fluorine in waste liquid

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1293565A (en) *	1969-05-03	1972-10-18	Aspro Nicholas Ltd	Aminophthalazines and pharmaceutical compositions thereof
EP0976745B1 (en)	1997-03-26	2003-08-13	Taisho Pharmaceutical Co., Ltd	4-tetrahydropyridylpyrimidine derivatives
KR20000069311A (ko) *	1997-04-22	2000-11-25	디르크 반테	Ｃｒｆ 길항성 퀴노- 및 퀴나졸린
EP0994877A1 (en)	1997-07-03	2000-04-26	Du Pont Pharmaceuticals Company	Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
JPH11335376A (ja)	1998-05-25	1999-12-07	Taisho Pharmaceut Co Ltd	アリールテトラヒドロピリジン誘導体
JPH11335373A (ja)	1998-05-25	1999-12-07	Taisho Pharmaceut Co Ltd	アリールメチレンピペリジノピリミジン誘導体
JP2000086663A (ja) *	1998-09-09	2000-03-28	Taisho Pharmaceut Co Ltd	アリールテトラヒドロピリジン誘導体
US6600038B1 (en)	1999-03-11	2003-07-29	Taisho Pharmaceutical Co., Ltd.	Carbamoyl tetrahydropyridine derivatives

2001
- 2001-07-03 AR ARP010103171A patent/AR028782A1/es unknown
- 2001-07-04 CA CA002412287A patent/CA2412287A1/en not_active Abandoned
- 2001-07-04 AU AU2001269437A patent/AU2001269437B2/en not_active Ceased
- 2001-07-04 SK SK13-2003A patent/SK132003A3/sk unknown
- 2001-07-04 BR BR0112166-9A patent/BR0112166A/pt not_active IP Right Cessation
- 2001-07-04 AT AT01947819T patent/ATE353885T1/de not_active IP Right Cessation
- 2001-07-04 TW TW090116391A patent/TW591022B/zh not_active IP Right Cessation
- 2001-07-04 CN CNA2004100338762A patent/CN1535968A/zh active Pending
- 2001-07-04 DE DE60126616T patent/DE60126616T2/de not_active Expired - Fee Related
- 2001-07-04 PL PL01358411A patent/PL358411A1/xx not_active Application Discontinuation
- 2001-07-04 CN CNB018120016A patent/CN1260225C/zh not_active Expired - Fee Related
- 2001-07-04 IL IL15371801A patent/IL153718A0/xx unknown
- 2001-07-04 CZ CZ20024229A patent/CZ20024229A3/cs unknown
- 2001-07-04 HU HU0301165A patent/HUP0301165A2/hu unknown
- 2001-07-04 HR HR20030074A patent/HRP20030074A2/hr not_active Application Discontinuation
- 2001-07-04 US US10/311,277 patent/US6852732B2/en not_active Expired - Fee Related
- 2001-07-04 AU AU6943701A patent/AU6943701A/xx active Pending
- 2001-07-04 EE EEP200300007A patent/EE200300007A/et unknown
- 2001-07-04 EA EA200300118A patent/EA005289B1/ru not_active IP Right Cessation
- 2001-07-04 KR KR10-2003-7000112A patent/KR20030015368A/ko not_active Withdrawn
- 2001-07-04 JP JP2002507801A patent/JP2004502685A/ja active Pending
- 2001-07-04 EP EP01947819A patent/EP1299378B1/en not_active Expired - Lifetime
- 2001-07-04 WO PCT/JP2001/005806 patent/WO2002002549A1/en not_active Ceased
- 2001-07-04 MX MXPA02012820A patent/MXPA02012820A/es unknown
2002
- 2002-12-11 BG BG107374A patent/BG107374A/bg unknown
- 2002-12-19 NO NO20026125A patent/NO20026125L/no not_active Application Discontinuation
2004
- 2004-08-06 US US10/912,185 patent/US7160900B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EA200300118A1 (ru)	2003-08-28
HUP0301165A2 (hu)	2003-08-28
US20040034061A1 (en)	2004-02-19
TW591022B (en)	2004-06-11
DE60126616D1 (de)	2007-03-29
ATE353885T1 (de)	2007-03-15
EP1299378B1 (en)	2007-02-14
CN1439001A (zh)	2003-08-27
EA005289B1 (ru)	2004-12-30
BG107374A (bg)	2004-09-30
HK1057042A1 (en)	2004-03-12
AR028782A1 (es)	2003-05-21
KR20030015368A (ko)	2003-02-20
EP1299378A1 (en)	2003-04-09
JP2004502685A (ja)	2004-01-29
CN1260225C (zh)	2006-06-21
IL153718A0 (en)	2003-07-06
US20050009874A1 (en)	2005-01-13
NO20026125L (no)	2003-02-04
DE60126616T2 (de)	2007-10-25
AU2001269437B2 (en)	2005-12-01
SK132003A3 (en)	2003-08-05
HRP20030074A2 (en)	2005-02-28
CZ20024229A3 (cs)	2003-06-18
WO2002002549A1 (en)	2002-01-10
CA2412287A1 (en)	2002-01-10
NO20026125D0 (no)	2002-12-19
MXPA02012820A (es)	2003-05-14
PL358411A1 (en)	2004-08-09
CN1535968A (zh)	2004-10-13
US6852732B2 (en)	2005-02-08
BR0112166A (pt)	2003-09-02
EP1299378A4 (en)	2004-01-28
AU6943701A (en)	2002-01-14
US7160900B2 (en)	2007-01-09

Publication	Publication Date	Title
EE200300007A (et)	2004-08-16	Heterotsüklilised tetrahüdropüridino- või piperidinoderivaadid
AR028343A1 (es)	2003-05-07	Derivados de pirrolidina y piperidina
NO20023787D0 (no)	2002-08-09	Piperazin- og piperidinderivater
CY2017030I2 (el)	2018-04-04	Παραγωγα πυρρολιδινης και πιπεριδινης ως ανταγωνιστες νκ1
NO20013538L (no)	2001-09-17	Piperidin, tetrahydropyridin og piperazinderivater, deres fremstilling og anvendelse
DE60038481D1 (de)	2008-05-15	Kristalline form des (r)-2-äää3-methyl-4-(2,2,2-trifluorethoxy)-2-pyridinylümethylüsulfinylü-1h-benzimidazols
NO20032596D0 (no)	2003-06-06	Heterosykliske etersubstituerte imidazokinoliner
AR028567A1 (es)	2003-05-14	Nuevos derivados de fenil-propargileter
IS6366A (is)	2002-04-29	Heterósýklísk setin pýrazólón
AR028596A1 (es)	2003-05-14	Nuevos derivados de fenilglicina
DK1131308T3 (da)	2004-06-28	Piperazin- og piperidinderivater
DE60203481D1 (de)	2005-05-04	Piperidinderivate als neurokinin 1 antagonisten
PT1283838E (pt)	2004-04-30	Compostos de piperazina e de piperidina
NO20032315D0 (no)	2003-05-22	4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer
ATE247105T1 (de)	2003-08-15	Antipsychotische 4-(1h-indolyl-1-yl)-1- substituierte piperidine derivate
NO20025659L (no)	2002-11-25	Heterocykliske forbindelser
PT1322592E (pt)	2004-12-31	Derivados substituidos de 1-aminobutan-3-ol
NO20006547D0 (no)	2000-12-21	Salter av paroxetine
ATE315025T1 (de)	2006-02-15	Ethansulfonyl-piperidin-derivate
ATE506357T1 (de)	2011-05-15	Heterocyclische aminoalkylpyridinderivate als psychopharmaka
NO20003960D0 (no)	2000-08-04	Salter av paroksetin
IS6468A (is)	2002-07-11	Heterósýklískar amíð afleiður
PT1440067E (pt)	2005-02-28	Derivados n-formilo de paroxetina
DE60139781D1 (de)	2009-10-15	4-substituierte piperidinverbindung
NO20004583D0 (no)	2000-09-14	Krystallinsk form av paroxetine